Abeona Therapeutics, a rare genetic disease focused biopharma, has named Carsten Thiel as its new chief executive officer, it was reported on Friday.
Thiel, who was formerly serving as the company's executive vice president and chief commercial officer, brings experience in leading commercial operations to his new position. Following a 25-year career in the biopharmaceutical industry, Thiel has held numerous roles for several biopharma's including Amgen and Roche.
Steven Rouhandeh, executive chairman of Abeona, said, 'As CEO, Carsten Thiel brings a unique combination of extensive experience in research and global rare disease commercialisation to Abeona. In his recent positions, he successfully created value by building cohesive talented teams, driving the commercial success of multiple products globally and fostering entrepreneurial culture; all key aspects that will be critical to our success in these areas in the years ahead.'
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer